Lamotrigine and Abortion spontaneous - a phase IV clinical study of FDA data

Summary:

Abortion spontaneous is found among people who take Lamotrigine, especially for people who are 30-39 old, have been taking the drug for 1 - 6 months.

The phase IV clinical study analyzes which people take Lamotrigine and have Abortion spontaneous. It is created by eHealthMe based on reports of 61,601 people who have side effects when taking Lamotrigine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 30, 2023

61,601 people reported to have side effects when taking Lamotrigine.
Among them, 676 people (1.1%) have Abortion spontaneous.

What is Lamotrigine?

Lamotrigine has active ingredients of lamotrigine. It is often used in bipolar disorder. eHealthMe is studying from 65,080 Lamotrigine users for its effectiveness, alternative drugs and more.

What is Abortion spontaneous?

Abortion spontaneous (naturally occurring miscarriage) is found to be associated with 1,748 drugs and 1,241 conditions by eHealthMe.

Number of Lamotrigine and Abortion spontaneous reports submitted per year:

Could Lamotrigine cause Abortion spontaneous?

* Approximation only. Some reports may have incomplete information.

Do you take Lamotrigine and have Abortion spontaneous?

Check whether Abortion spontaneous is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Alonso-Navarro H, Montes JM, Plaza-Nieto JF, Jiménez-Jiménez FJ, "Cataplexy Possibly Associated With Lamotrigine", Journal of clinical psychopharmacology, 2016 Aug .
Gupta MC, Khanna J, Mathur R, Mittal N, "Lamotrigine-induced fulminant hepatic failure: an unusual presentation", IMSEAR, 2015 Jan .

Related studies

How severe was Abortion spontaneous and when was it recovered:

Abortion spontaneous in Lamotrigine

Expand to all the drugs that have ingredients of lamotrigine:

Abortion spontaneous and drugs with ingredients of lamotrigine (1,092 reports)

Alternative drugs to, pros and cons of Lamotrigine:

Lamotrigine (65,080 reports)

Common Lamotrigine side effects:

Browse all side effects of Lamotrigine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Abortion spontaneous treatments and more:

Abortion spontaneous (41,271 reports)

COVID vaccines that are related to Abortion spontaneous:

Common drugs associated with Abortion spontaneous:

All the drugs that are associated with Abortion spontaneous:

Abortion spontaneous (1,748 drugs)

Common conditions associated with Abortion spontaneous:

Birth control: 3,707 reports
Multiple sclerosis: 3,336 reports
Hiv infection: 2,648 reports
Epilepsy: 2,207 reports

All the conditions that are associated with Abortion spontaneous:

Abortion spontaneous (1,241 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lamotrigine (the active ingredients of Lamotrigine) and Lamotrigine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.